OMX Copenhagen 20
1.417,98
PKT
-17,73
PKT
-1,23
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.12.12 | Carlsberg outperform | Exane-BNP Paribas SA | |
| 04.12.12 | FFLSmidth buy | UBS AG | |
| 04.12.12 | Coloplast A-S (B) equal-weight | Morgan Stanley | |
| 03.12.12 | Danske Bank underperform | Exane-BNP Paribas SA | |
| 03.12.12 | DSV A-S equal-weight | Morgan Stanley | |
| 29.11.12 | Novo Nordisk sell | Société Générale Group S.A. (SG) | |
| 29.11.12 | A.P. Moeller - Maersk A-S (B) underperform | Cheuvreux SA | |
| 29.11.12 | A.P. Moeller - Maersk A-S (B) neutral | Nomura | |
| 29.11.12 | Danske Bank buy | Deutsche Bank AG | |
| 19.11.12 | A.P. Moeller - Maersk A-S (B) neutral | Nomura | |
| 19.11.12 | Novo Nordisk kaufen | Die Actien-Börse | |
| 12.11.12 | Novo Nordisk neutral | Nomura | |
| 12.11.12 | Novo Nordisk equal-weight | Morgan Stanley | |
| 12.11.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Carlsberg outperform | Exane-BNP Paribas SA | |
| 08.11.12 | A.P. Moeller - Maersk A-S (B) neutral | Nomura | |
| 08.11.12 | Carlsberg buy | Nomura | |
| 08.11.12 | Carlsberg hold | Deutsche Bank AG | |
| 08.11.12 | Carlsberg sell | Société Générale Group S.A. (SG) | |
| 07.11.12 | Novo Nordisk buy | UBS AG | |
| 07.11.12 | Novo Nordisk neutral | Sarasin Research | |
| 07.11.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 07.11.12 | Novo Nordisk neutral | Nomura | |
| 07.11.12 | Novo Nordisk sell | Société Générale Group S.A. (SG) | |
| 07.11.12 | Novo Nordisk neutral | J.P. Morgan Cazenove | |
| 05.11.12 | Carlsberg neutral | UBS AG | |
| 05.11.12 | DSV A-S hold | Vontobel Research | |
| 02.11.12 | Carlsberg outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Carlsberg sell | Société Générale Group S.A. (SG) | |
| 02.11.12 | DSV A-S reduce | Sarasin Research | |
| 02.11.12 | DSV A-S hold | Vontobel Research | |
| 01.11.12 | Danske Bank buy | Deutsche Bank AG | |
| 01.11.12 | Danske Bank hold | Société Générale Group S.A. (SG) | |
| 01.11.12 | Novo Nordisk sell | Société Générale Group S.A. (SG) | |
| 31.10.12 | DSV A-S reduce | Nomura | |
| 31.10.12 | Danske Bank underperform | Exane-BNP Paribas SA | |
| 31.10.12 | Danske Bank reduce | Nomura | |
| 31.10.12 | Novo Nordisk neutral | Sarasin Research | |
| 31.10.12 | Danske Bank overweight | J.P. Morgan Cazenove | |
| 31.10.12 | Danske Bank neutral | UBS AG |